Intracavernosal Exosomes vs. Rectal Ozone for Post-RARP Erectile Dysfunction
Key facts
- Who runs it
- Medipol University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 1 Apr 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Urine-Derived Exosomes (USC-Exos)
- Rectal Medical Ozone Insufflation
- Daily Phosphodiesterase type 5 (PDE5) Inhibitor
- Record updated
- 16 July 2026
Who can take part
- Age
- 45 years to 75 years
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- History of Robotic-Assisted Radical Prostatectomy (ns-RARP) for localized prostate cancer
- Normal preoperative erectile function (retrospective IIEF-5 score > 21)
- Presence of a stable, sexually active heterosexual relationship
- Inadequate response or intolerance to maximum dose, on-demand oral Phosphodiesterase type 5 inhibitors (PDE5i)
Who cannot take part
- Concomitant use of any intraurethral alprostadil, vacuum erection devices (VED), or testosterone replacement therapy during the study period
- History of adjuvant or salvage pelvic radiotherapy / androgen deprivation therapy (ADT)
- Presence of severe anatomical penile deformities (e.g., active phase Peyronie's disease)
- History of major cardiovascular events (myocardial infarction, stroke) within the preceding 6 months
- Uncontrolled endocrinological (e.g., HbA1c > 8.5%) or cardiovascular comorbidities
- Current use of systemic anticoagulants (excluding low-dose prophylactic aspirin)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 45 and 75 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective, randomized, controlled trial aims to evaluate and compare the therapeutic efficacy of intracavernosal urine-derived exosomes and systemic rectal ozone therapy in patients experiencing erectile dysfunction (ED) post-robotic-assisted radical prostatectomy (RARP). Patients will be randomized into two distinct intervention arms. The primary objective is to assess the functional recovery of the erectile tissue via the International Index of Erectile Function (IIEF-5) over a 6-month follow-up period. Secondary endpoints include penile hemodynamic alterations and overall health-related quality of life.
The 3 groups in the trial
- Intracavernosal Urine-Derived Exosomes (USC-Exos)Treatment being tested
Participants randomized to this arm will receive targeted intracavernosal injections of cell-free, urine-derived exosomes. The intervention aims to evaluate the proangiogenic and regenerative effects of the exosome secretome on the cavernous tissue following radical prostatectomy.
Treatment: Urine-Derived Exosomes (USC-Exos)
- Rectal Medical Ozone TherapyTreatment being tested
Participants randomized to this arm will receive protocolized systemic rectal medical ozone insufflation. This arm evaluates the systemic antioxidant, anti-inflammatory, and tissue oxygenation benefits of ozone therapy on post-operative erectile functional recovery.
Treatment: Rectal Medical Ozone Insufflation
- Standard Penile RehabilitationExisting treatment, for comparison
Participants randomized to this arm will receive the current standard of care for post-prostatectomy penile rehabilitation. This serves as the active control group to benchmark the efficacy of the experimental regenerative therapies.
Treatment: Daily Phosphodiesterase type 5 (PDE5) Inhibitor
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intracavernosal Exosomes Versus Rectal Ozone Therapy for Erectile Dysfunction Following Robotic-Assisted Radical Prostatectomy
- Criteria questions
- Built from NCT07707505, who can take part
- Record updated
- 16 July 2026